Abstract
Cephalotaxus, the only genus of the family Cephalotaxaceae with eight species and few varieties known so far, is mostly native to China. Seven of the eight known Cephalotaxus species growing in China are: C. fortunei Hook. f., C. hainanensis Li, C. wilsoniana Hay., C. mannü Hook, f., C. oliveri Mast., C. lanceolata K.M. Feng, and C. sinensis Li. C. harringtonia occurs in Japan and C. mannii is also found in India [1, 2].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Zhu DY (1987) Recent advances on the active components in Chinese medicines. Abstr Chin Medicines 1:251–286
Alkaloids Group, Laboratory of Plant Chemistry, Institute of Botany, Academia Sinica (1980) Studies on alkaloids of Cephalotaxus sinensis (Rehd. et Will.) Li. Acta Bot Sin 22:156–160
Powell RG, Weisleder D, Smith CR Jr (1972) Antitumor alkaloids from Cephalotaxus harringtonia; structure and activity. J Pharm Sci 61:1227–1230
Well ME, Eddy CR, Williaman JJ, Correll DS, Schuber BG, Gentry HS (1954) Steroidal sapogenins. XII. Survey of plant for steroidal sapogenins and other constituents. J Am Pharm Assoc 43:503–505
Kariyone T, Takahashi M, Nitta A, Tsunehisa Y (1956) The alkaloid of coniferous plants. I. J Pharm Soc Jpn 76:611
Hsu HY (1957) Alkaloids in leaves of gymnosperms in Taiwan. I. J Taiwan Pharm 9:5–8
Paudler WW, Kerley GI, McKay J (1963) The alkaloids of Cephalotaxus drupacea and Cephalotaxus fortunei. J. Org Chem 28:2194–2197
Powell RG, Weisleder D, Smith CR Jr, Wolff IA (1969) Structure of cephalotaxine and related alkaloids. Tetrahedron Lett 4081–4084
Abraham DJ, Rosenstein RD, McGandy EL (1969) Single crystal X-ray structures of chemo-therapeutic agents. II. The structure of cephalotaxine methiodide. Tetrahedron Lett 4085–4086
Arora SK, Bates RB, Grady RA, Powell RG (1974) Crystal and molecular structure of cephalotaxine p-bromobenzoate. J Org Chem 39:1269–1271
Arora SK, Bates RB, Grady RA, Germain G, Declercq P, Powell RG (1976) Crystal and molecular structure of cephalotaxine. J Org Chem 41:551–554
Powell RG, Weisleder D, Smith CR Jr, Rohwedder WK (1970) Structures of harringtonine, isoharringtonine and homoharringtonine. Tetrahedron Lett 815–818
Mikolajczak KL, Powell RG, Smith CR Jr (1972) Deoxyharringtonine, a new antitumor alkaloid from Cephalotaxus: structure and synthetic studies. Tetrahedron 28:1995–2001
Brandange S, Josephson S, Valien S (1974) Absolute configurations of 2-alkylmalic acids. Acta Chem Scand [B]28:153–156
Brandange S, Josephson S, Valien S, Powell RG (1974) Absolute configuration of 2,3-dihy-droxy-2-isopentyl-butanedioic acid, a component of the alkaloid isoharringtonine. Acta Chem Scand [B]28:1237–1248
Ipaktchi T, Weinreb SM (1973) Relative configuration of the diacid sidechain of isoharringtonine. Tetrahedron Lett 3895–3898
Powell RG (1972) Structures of homoerythrina alkaloids from Cephalotaxus harringtonia. Phytochemistry 11:1467–1472
Powell RG, Mikolajczak KL (1973) Desmethylcephalotaxinone and its correlation with cephalotaxine. Phytochemistry 12:2987–2991
Fitzgerald JS, Johns SR, Lamberton JA, Sioumis AA (1969) Alkaloids of Schelhammera pedunculata (Liliaceae). I. Isolation of the alkaloids schelhammerine and schelhammeridine. Aust J Chem 22:2187–2201
Johns SR, Lamberton JA, Sioumis AA, Suares H (1969) Alkaloids of Schelhammera pedunculata (Liliaceae). II. Reactions of schelhammeridine. Aust J Chem 22:2203–2218
Johns SR, Lamberton JA, Sioumis AA (1969) Alkaloids of Schelhammera pedunculata (Liliaceae). III. The structures of schelhammericine and alkaloids A, B, E, G, H, J and K. Aust J Chem 22:2219–2231
Powell RG, Weisleder D, Smith CR Jr, Wolff IA (1969) Structure of cephalotaxine and related alkaloids. Tetrahedron Lett 4081 – 4084
Powell RG, Madrigal RV, Smith CR Jr, Mikolajczak KL (1974) Alkaloids of Cephalotaxus harringtonia var. drupacea. 11-Hydroxycephalotaxine and drupacine. J Org Chem 39:676–680
Asada S (1973) Alkaloids isolated from the Cephalotaxus drupacea. Yakugaku Zasshi 93:916–924
Chinese Academy of Medical Sciences, Chinese People’s Liberation Army 187th Hospital (1976) Studies on the antitumor constituents of Cephalotaxus hainanensis Li. Acta Chim Sin 34:283–293
Xue Z, Xu LZ, Chen DH, Huang L (1981) Studies on minor alkaloids of Cephalotaxus hainanensis Li. Acta Pharm Sin 16:752–756
Sun NJ, Liang XT (1981) Studies on the structure of a new antitumor constituent, hainanensine. Acta Pharm Sin 16:24–26
Sun NJ, Liang HT (1980) Structure of a new antitumor constituent, hainanensine. Chin Pharm Bull 15:39–40
Xue Z, Sun NJ, Chen DH, Xu LZ, Chen WM, Ren LJ, Liang XT, Huang L (1982) The studies of chemical constituents of Cephalotaxus hainanensis Li. In: Wang Y (ed) Chem Nat Prod, Proc Sino-Am Symp 1980. Science Press, Beijing, 195–199
Paudler WW, McKay J (1973) The structures of some of the minor alkaloids of Cephalotaxus fortunei. J Org Chem 38:2110–2112
Ma GE, Lin LT, Chao TY, Fan HC (1977) Studies on the alkaloids of Cephalotaxus. I. Isolation and characterization of anticancer alkaloids and a new alkaloid (+)-acetylcephalo-taxine from Cephalotaxus fortunei. Acta Chim Sin 35:201–208
Ma GE, Lin LT, Chao TY, Fan HC (1978) Studies on alkaloids of Cephalotaxus. II. Four minor alkaloids from Cephalotaxus fortunei. Hook. f. and the structure of cephalofortuneine. Acta Chim Sin 36:129–136
Lin W, Chen RT, Xue Z (1985) Studies on the minor alkaloids of Cephalotaxus fortunei Hook. f. Acta Pharm Sin 20:283–287
Ma GE, Lu CE, ElSohly HN, ElSohly MA, Turner CE (1983) Studies on the alkaloids of Cephalotaxus. IV. Fortuneine, a homoerythrina alkaloid from C. fortunei. Phytochemistry 22:251–253
Ma GE, Sun GQ, ElSohly MA, Turner CE (1982) Studies on the alkaloids of Cephalotaxus. III. 4-Hydroxycephalotaxine, a new alkaloid from Cephalotaxus fortunei. J Nat Prod 45:585–589
Ma GE, Lu CE, Fan GJ (1982) Isolation and identification of harringtonine and other alkaloids from seeds of Cephalotaxus fortunei. Chin Pharm Bull 17:205–206
Ma YQ, Guo MR, Zhu TP, Ma GE, Lu CE, Huang H, Yang YH (1984) Determination of harringtonine and homoharringtonine, antileukemic alkaloids in Cephalotaxus fortunei Hook. f. and C. sinensis (Rehd. et Wils) Li. Acta Bot Sin 26:405–410
Institute of Botany, Academia Sinica (1980) Studies on alkaloids of Cephalotaxus sinensis (Rehd. et Wils.) Li. Acta Bot Sin 22:156–160
Ren LJ, Xue Z (1981) Studies on the antitumor constituents of Cephalotaxus sinensis. Chin Trad Herb Drugs 12:241–244
Powell RG, Mikolajczak KL, Weisleder D, Smith CR Jr (1972) Alkaloids of Cephalotaxus wilsoniana. Phytochemistry 11:3317–3320
Furukawa H, Itoigawa M, Haruna M, Jinno Y, Ito K, Lu ST (1976) Alkaloids of Cephalotaxus wilsoniana Hay. Yakugaku Zasshi 96:1373–1377
Zhang FX, Wang ZH, Pan WD, Li YJ, Mai LT, Sun JQ, Ma GE (1978) A study on the antitumor plant Cephalotaxus oliveri Mast. Acta Bot Sin 20:129–134
Pan WD, Mai LT, Li YJ (1983) Studies on the variation of harringtonine content in Cephalotaxus oliveri with seasons, parts and ages of the tree. Bull Chin Mat Med 8:15–16
Powell RG, Miller RW, Smith CR Jr (1979) Cephalomannine: a new antitumor alkaloid from Cephalotaxus mannii. J Chem Soc Chem Commun 102–104
Huang L, Xue Z (1984) Cephalotaxus alkaloids. Alkaloids 23:157–226
Dolby LJ, Nelson SJ, Senkovich D (1972) Study of the synthesis of cephalotaxine. I. J Org Chem 37:3691–3695
Weinstein B, Craig AR (1976) A synthetic approach to the cephalotaxine skeleton. J Org Chem 41:875–878
Tse I, Snieckus V (1976) Photochemical preparation of dihydropyrrolo[2,1-b] [3] benzazepines. A Cephalotaxus alkaloid synthon. J Chem Soc Chem Commun 505–506
Auerbach J, Weinreb SM (1972) The total synthesis of cephalotaxine. J Am Chem Soc 94:7172–7173
Weinreb SM, Auerbach J (1975) Total synthesis of the Cephalotaxus alkaloids. Cephalotaxine, cephalotaxinone and demethylcephalotaxinone. J Am Chem Soc 97:2503–2506
Semmelhack MF, Chong BP, Jones LD (1972) Total synthesis of Cephalotaxus alkaloids. J Am Chem Soc 94:8629–8630
Semmelhack MF, Stauffer RD, Rogerson TD (1973) Nucleophilic aromatic substitution via a new nickel-catalyzed process and via the SRN1 reaction. Improved synthesis of cephalotaxinone. Tetrahedron Lett 4519–4522
Semmelhack MF, Chong BP, Stauffer RD, Rogerson TD, Chong A, Jones LD (1975) Total synthesis of the Cephalotaxus alkaloids. A problem in nucleophilic aromatic substitution. J Am Chem Soc 97:2507–2516
Semmelhack MF, Margar TM (1977) Cyclizations of enolates onto aromatic rings via the photo-SRN1 reaction. Preparative and mechanistic aspects. J Org Chem 42:1481–1482
Mikolajczak KL, Smith CR Jr, Weisleder D, Kelly TR, McKenna JC, Christenson PA (1974) Synthesis of deoxyharringtonine. Tetrahedron Lett 283–286
Huang WK, Li YL, Pan SF (1976) Crystallization of (oxoacyl)cephalotaxine, a key intermediate for deoxyharringtonine synthesis. Kexue Tongbao 21:178
Huang WK, Li YL, Pan SF (1980) Synthesis of deoxyharringtonine and separation of its stereomers. Sci Sin [Engl] 23:835–846
Li SW, Dai JY (1975) A study on the deoxyharringtonine and its analogs. Acta Chim Sin 33:75–78
Institute of Pharmacology (1976) Partial synthesis of harringtonine. Kexue Tongbao 21:512
Huang L, Xi YG, Guo JY, Liu DK, Xu SP, Wu KM, Chen JC, Jiang YZ, Cao YS, Guo Z, Li L, Zhang M, Chu F (1979) Partial synthesis of harringtonine. Sci Sin [Engl] 22:1333–1345
Kelly TR, McNutt RW Jr, Montury M, Tosches NP, Mikolajczak KL, Smith CR Jr, Weisleder D (1979) Preparation of harringtonine from cephalotaxine. J Org Chem 44:63–67
Zhao ZZ, Xi YG, Zhao HF, Hou JY, Zhang JY, Wang ZH (1980) Partial synthesis of homo-harringtonine from cephalotaxine. Acta Pharm Sin 15:46–49
Wang YK, Li YL, Pan HF, Li CP, Huang WK (1980) Synthesis of antitumor alkaloids. Kexue Tongbao 25:576
Hiranuma S, Hudlicky T (1982) Synthesis of homoharringtonine and its derivative by partial esterification of cephalotaxine. Tetrahedron Lett 23:3431–3434
Li YN, Wu KM, Huang L (1982) Synthesis of isoharringtonine and separation of the isomers. Acta Pharm Sin 17:866–867
Pan XF, Li YL, Li SB, Tian J, Zhang DN, Cui YX, Cheng PG, Wang YK, Huang WK (1982) Synthesis of isoharringtonine. Kexue Tongbao 27:1048
Chinese Academy of Medical Sciences, Institute of Materia Medica (1978) Separation and identification of harringtonine and epiharringtonine. Kexue Tongbao 23:696–699
Zhang GD, Zhou ZH, Guo YS, Guo JY, Liu DK, Chu FM (1981) Isolation and determination of the two epimers of partially synthesized harringtonine. Anal Chem 291–295
Huang L, Fang QN, Cheng JC, Jiang ZY (1983) Semisynthetic diastereoisomers — separation and identification of harringtonine and epiharringtonine by preparative high-performance liquid chromatography. Anal Chem 158–159
Li YN, Wu KM, Huang L (1984) Synthesis of isoharringtonine and separation of the isomers. Acta Pharm Sin 19:582–589
Cheng JC, Zhang JH, Zhang QB, Yang J, Huang L (1984) Stereospecific synthesis of deoxyharringtonine and homoharringtonine. Acta Pharm Sin 19:178–183
Mioskowski C, Solladie G (1980) Synthésis asymétriques de β-hydroxy acids par condensation d’anions énolates d’esters α-sulfïnyle chiraux sur des composés carbonyles. Tetrahedron 36:227–236
Steffens GL, Buta JG, Gregory LE, Momdava NB, Meudt WJ, Worley JF (1979) New plant growth regulators isolated from higher plants. In: Geissbuehler H (ed) Advances in Pestic Sciences, Vol. 2. Pergamon, Oxford, pp 343–346
Flippen-Anderson JL, Duesler E (1979) Harringtonolide: a complex tropone. Acta Crystallogr [B]35:1253–1254
Sun NJ, Xue Z, Liang XT, Huang L (1979) Studies on the structure of a new antitumor agent — hainanolide. Acta Pharm Sin 14:39–44
Bao GH, He CH, Xu CF (1983) Crystal structure of hainanolide. Acta Acad Med Sin 5:89–93
Xue Z, Sun NJ, Liang XT (1982) Studies on the structure of hainanolidol. Acta Pharm Sin 17:236–237
Sun NJ, Zhao ZF, Chen RT, Lin W, Zhou YZ (1981) Isolation and identification of the antitumor component — hainanolide from Cephalotaxus fortunei. Acta Pharm Sin 16:233–234
Khan NU, Ilyas M, Rahman W, Okigawa M, Kawano N (1971) Occurrence of biflavones in Cephalotaxus. Phytochemistry 10:2541–2542
Ishratullah K, Rahman W, Okigawa M, Kawano N (1981) Biflavones from the leaves of Cephalotaxus harringtonia C. Koch (Cephalotaxacaeae). Indian J Chem [B] 20:935–936
Aqil M, Rahman W, Okigawa M, Kawano N (1976) Isolation of C-methylbiflavone from Cephalotaxus and use of lanthanide shift reagent in deciding 6- or 8-C-methylflavone. Chem Ind 567–568
Aqil M, Rahman W, Hasaka N, Okigawa M, Kawano N (1981) A C-methylbiflavone from Cephalotaxus harringtonia K. Koch. J Chem Soc Perkin Trans I 1389–1392
Ma ZW, He GF, Yin WF (1984) Biflavonoids in the leaves of Cephalotaxus fortunei Hook. f. var. alpina native to China. Acta Bot Sin 26:416–418
Yang WW, Xing YQ, Xu JY, Shi XF (1983) Isolation of chrysoeriol from Cephalotaxus fortunei Hook. f. J Lanzhou Univ [Natl Sci] 19:114
Yang WW, Xing YQ, Xu JY, Shi XF (1983) Isolation of chrysoeriol from Cephalotaxus fortunei. Chin Trad Herb Drugs 14:164
Corbett TH, Griswold DP Jr, Roberts BJ, Peckham JC, Schabel FM Jr (1977) Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinoma. Cancer 40:2660–2680
Takeda S, Yajima N, Kitazato K, Unemi N (1982) Antitumor activities of harringtonine and homoharringtonine, Cephalotaxus alkaloids which are active principles from plant by intraperitoneal and oral administration. J Pharmacobiodyn 5:841–847
Baaske DM, Heinstein P (1977) Cytotoxicity and cell cycle specificity of homoharringtonine. Antimicrob Agents Chemother 12:298–300
Jiang TL, Salmon SE, Liu RM (1983) Activity of camptothecin, harringtonine, cantharidin and cucumae in the human tumor stem cell assay. Eur J Cancer Clin Oncol 19:263–270
Jiang TL, Liu RH, Salmon SE (1983) Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells. Invest New Drugs 1:21–25
Cobb WR, Bogden AE, Reich SD, Griffm TW, Kelton DE, LePage DJ (1983) Activity of two phase I drugs, homoharringtonine and tricyclic nucleotide, against surgical expiants of human tumor in the 6-day subrenal capsule assay. Cancer Treat Rep 67:173–178
Huang MT (1975) Harringtonine, an inhibitor of initiation of protein biosynthesis. Mol Pharmacol 11:511–519
Tscherne JS, Pestka S (1975) Inhibition of protein synthesis in intact HeLa cells. Antimicrob Agents Chemother 8:479–487
Fresno M, Jimenez A, Vazquez D (1977) Inhibition of translation in eukaryotic systems by harringtonine. Eur J Biochem 72:323–330
Si JY, Son KX, Hu WW, Men SS, Han R, Pan ZK, Li ZR (1979) Ultrastructural study on the effect of harringtonine on mouse leukemia L-1210 cells. Acta Biochem Biophys Sin 11:333 – 338
Wang ZW, Hsu B (1980) Electron microscopic studies of the effect of homoharringtonine on hepatocyte nucleolus and myocardiac cells. Acta Biochim Biophys Sin 12:231–235
Wu GY, Fang FD, Han R, Sun ZR (1981) Studies on the mechanism of the inhibition of harringtonine on DNA synthesis. I. Effects of harringtonine on DNA template and metabolism. Acta Biochim Biophys Sin 13:509–515
Wu GY, Fang FD, Zuo J, Han R, Sun ZR (1982) Studies on mechanism of inhibition of harringtonine on DNA and on protein synthesis. Acta Acad Med Sin 4:78–81
Yang SR, Fang FD, Wu GY (1982) Effects of harringtonine on nucleotide metabolism in tumor cells. Acta Pharm Sin 17:721–727
Wu GY, Qiou CC (1982) Studies on the mechanism of inhibition of harringtonine on DNA biosynthesis. II. Effect of harringtonine on DNA polymerase. Acta Biochim Biophys Sin 14:553–558
Qiu CC, Wu GY (1984) Studies on the mechanism of inhibition of harringtonine on DNA synthesis. III. Kinetics of inhibition by harringtonine and comparison with its analogs. Acta Biochim Biophys Sin 16:645–649
102/ Pan ZK, Han R, Wang YC (1980) The cytokinetic effects of harringtonine on leukemia L1210 cells. I. Autoradiographic studies. Acta Biochim Biophys Sin 12:13–20
Xu YT, Du CZ (1981) Effect of harringtonine and its related alkaloids on DNA synthesis in mice bearing leukemias P388, L615 and normal mice. Acta Pharmacol Sin 2:252–256
Xu YT, Du CZ, Zhang FR, Ji XJ (1981) Effect of harringtonine alkaloids on the protein biosynthesis in mouse leukemias L615 and P388 cells. Acta Pharm Sin 16:661–666
Li ZR, Sun ZR, Han R (1983) Effects of harringtonine and related alkaloids on the cAMP levels of L615 and P388 leukemic cells. Acta Pharm Sin 18:303–306
Zhang YJ, Yu H, Luo XY, Zheng YX, Li WJ, Liu XL, Yuan YY (1979) Toxicological studies of harringtonine and homohamngtonine. Acta Pharm Sin 14:135–140
Lokhandwala MF, Sabouni MH, Jandhyala BS (1985) Cardiovascular actions of an experimental antitumor agent, harringtonine, in anesthetized dogs. Drug Dev Res 5:157–163
Wu GY, Fang FD, Zuo J, Han R, Sun ZR (1983) Epiharringtonine-induced enhancement of harringtonine inhibition on protein and DNA formation in tumor cells. Acta Acad Med Sin 5:157–160
Jiang DZ, Xu YH, Li MF, Yuan WD, Wang QR (1985) Lithium protects mouse bone marrow cells against the myelosuppressive effect of harringtonine. Bull Hunan Med Coll 10:307–311
Huang NJ, Chen SM (1986) Induction of induced chromosome aberrations and micronuclei by harringtonine. Acta Pharmacol Sin 7:173–175
Ji XJ, Liu JS, Liu ZM (1979) Metabolism of harringtonine. Acta Pharm Sin 14:234–240
Chinese Academy of Medical Sciences (1979) Chemical, pharmacological and clinical studies on the antitumor active principle of Cephalotaxus hainanensis Li. Chin J Oncol 1:176–182
Ji XJ, Liu Y, Lin H, Liu ZM (1982) Metabolism of homohamngtonine in rats and mice. Acta Pharm Sin 17:881–888
Harringtonine Cooperative Group (1975) Preliminary clinical evaluation of cephalotaxine ester in the treatment of acute leukemia. Natl Med J China 55:712
Zhang ZY (1981) Clinical analysis of the therapeutic effect of semisynthetic harringtonine in treating 55 cases of nonlymphocytic leukemia. Chin J Intern Med 20:667
Chang CN (1985) Antileukemia Chinese herbs and the effective ingredients. In: Chang HM, Yeung HW, Tso WW, Koo A (eds) Advances in Chinese Medical Material Research. World Scientific, Singapore, pp 369–375
Mikolajczak KL, Smith CR Jr, Powell RG (1974) Partial synthesis of harringtonine analogs. J Pharm Sci 63:1280–1283
Mikolajczak KL, Powell RG, Smith CR Jr (1975) Preparation and antitumor activity of a rearranged ester of cephalotaxine. J Med Chem 18:63–66
Mikolajczak KL, Smith CR Jr, Weisleder D (1977) Synthesis of cephalotaxine esters and correlation of their structures with antitumor activity. J Med Chem 20:328–332
Li SW, Sun HL, Lu SJ, Zhang SY, Lu FL, Dai JY, Xu YB (1981) Synthesis of cephalotaxine esters and their antitumor activity. Acta Pharm Sin 16:821–827
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tang, W., Eisenbrand, G. (1992). Cephalotaxus spp.. In: Chinese Drugs of Plant Origin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73739-8_38
Download citation
DOI: https://doi.org/10.1007/978-3-642-73739-8_38
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73741-1
Online ISBN: 978-3-642-73739-8
eBook Packages: Springer Book Archive